Legionella pneumophila: Legionnaires' Disease, Pathogenesis, Diagnosis, Treatment

A 62-year-old man who smokes is admitted with several days of high fever, a dry cough, and worsening breathlessness. Two things stand out. He is confused and his blood sodium is low, which is unusual for an ordinary chest infection, and he also has diarrhea. He was started on a standard penicillin-type antibiotic for pneumonia, but he is not improving. He had recently stayed in a hotel with a large air-conditioning and hot-water system. The clue is the mismatch: a severe pneumonia with confusion, low sodium, and diarrhea that does not respond to the usual antibiotic. The organism causing it lives inside his lung cells, where that antibiotic cannot reach it. This is Legionnaires' disease, caused by Legionella pneumophila.

Introduction

Legionella pneumophila is a faintly staining, gram-negative, pleomorphic rod. It causes two very different illnesses: Legionnaires' disease, a severe atypical pneumonia, and Pontiac fever, a mild self-limiting flu-like illness. One idea organizes the whole topic: Legionella is an intracellular organism that survives inside the very cells meant to kill it. This single fact explains how it causes disease, why cell-mediated immunity is the key defense, and why the antibiotics that work are the ones that get inside cells.

Legionella was first recognized in 1976, after an outbreak of pneumonia among people attending an American Legion convention in Philadelphia, which is how both the organism and the disease got their names.

Transmission

Legionella lives in water. It is found in warm-water systems such as cooling towers, hot tubs, hot-water tanks, large building plumbing, and air-conditioning systems. People catch Legionnaires' disease by inhaling a fine water aerosol (mist or vapor) that contains the bacteria, or sometimes by aspirating contaminated water. It is not spread from person to person, so there is no need to isolate patients from each other.

An important clue to how the organism causes human disease: in the environment, Legionella survives and multiplies inside free-living amoebae and within biofilms. Living inside amoebae is essentially practice for living inside human macrophages. The same tricks that let it survive inside an amoeba let it survive inside a human lung cell. This is why Legionella is naturally suited to be an intracellular human pathogen.

How Legionella causes disease

Legionella pneumophila is a facultative intracellular pathogen: it can survive and multiply inside host cells, and inside human lungs its target is the alveolar macrophage, the very cell whose job is to destroy inhaled bacteria. The disease is best understood as a step-by-step sequence.

Figure: Intracellular growth of Legionella pneumophila (Image source: M. S. Swanson and B. K. Hammer)

1. Reaching the lung. Inhaled or aspirated Legionella reaches the alveoli and attaches to the respiratory lining. Attachment is helped by type IV pili, heat-shock proteins, and a major outer membrane protein.
2. Being taken up by the macrophage. The alveolar macrophage engulfs Legionella, sometimes by a distinctive "coiling" phagocytosis. Normally, being eaten by a macrophage is the end for a bacterium.
3. Blocking its own destruction. This is the key step. Legionella prevents the phagosome (the bubble it sits in) from fusing with the lysosome (the compartment full of digestive enzymes). Because the two never fuse, the bacterium is not killed. It uses a specialized secretion system to inject proteins that reprogram the macrophage for this purpose.
4. Building a safe replication niche. Legionella then converts its phagosome into a protected compartment where it multiplies freely, hidden from the immune system.
5. Bursting out and spreading. When the bacteria have multiplied enough, the macrophage dies and releases them to infect new macrophages, and the cycle repeats. This intracellular growth drives the severe, spreading lung inflammation of Legionnaires' disease.

Why this matters for the whole disease. Because Legionella hides inside cells, antibodies alone cannot reach it. The main defense is cell-mediated immunity: activated T cells must switch the macrophages into a killing state. This is why people with weak cell-mediated immunity (transplant recipients, patients on steroids) are at high risk. It is also why the effective antibiotics are the ones that penetrate into cells, a point developed in the treatment section.

High-risk individuals

Older age (typically over 50 to 55 years)

• Smoking, which damages the alveolar macrophages and airway defenses
• Chronic lung disease
• High alcohol intake
• Weakened cell-mediated immunity (for example, transplant recipients and patients on corticosteroids), because clearing an intracellular organism depends on cell-mediated immunity

Note that Legionnaires' disease is uncommon in otherwise healthy young people; the risk factors above cluster in older, smoking, or immunocompromised patients.

Symptoms

Legionella causes two distinct illnesses:

Pontiac fever is mild. It is a self-limiting, flu-like illness that lasts about 2 to 5 days and resolves on its own without antibiotics. There is no pneumonia.

Legionnaires' disease is a severe atypical pneumonia. It causes high fever, chills, cough (often dry at first), shortness of breath, muscle aches, and headache, and can progress to multilobar consolidation with microabscesses. What makes it clinically distinctive are the features outside the lung, which are useful diagnostic clues:

• Confusion and other neurological changes
• Hyponatremia (low blood sodium), which is more common in Legionnaires' disease than in most other pneumonias
• Diarrhea and other gastrointestinal symptoms
• Relative bradycardia (a pulse slower than expected for the fever) in some patients

A severe pneumonia in an older or immunocompromised patient with confusion, low sodium, and diarrhea should raise suspicion of Legionnaires' disease, especially if it is not responding to a beta-lactam antibiotic.

Laboratory Diagnosis

Legionnaires’ disease is difficult to diagnose because pneumonia caused by Legionella is not easily distinguished from other forms of pneumonia.

Sample: Sputum, bronchoalveolar lavage, bronchial washing, and pleural fluid.

The grading system used for screening sputum for routine cultures is not applicable to Legionnaires’ disease because the sputum is non-purulent and may appear bloody or watery.

1.Microscopy

Figure: Gram-negative pleomorphic rods of Legionella pneumophila (Image source: CDC/ Dr. Gilda Jones)

A Gram stain of respiratory samples typically shows many neutrophils but no visible organisms, because Legionella stains very poorly and is easily missed. When seen at all, it appears as faint, pleomorphic gram-negative rods or coccobacilli. This mismatch (lots of neutrophils, no visible bacteria on Gram stain) is itself a clue. The organism is better shown in tissue using silver impregnation, Giemsa or fluorescent antibody., or direct fluorescent antibody staining.

2.Culture

Legionella is fastidious and will not grow on ordinary media. It specifically requires L-cysteine and iron, so it is grown on buffered charcoal yeast extract agar (BCYE) agar, which supplies both. A useful teaching point: Legionella grows on BCYE but not on blood agar, and this cysteine requirement is a defining feature. Plates are incubated at 35 to 37°C in about 5% CO₂ for 3 to 5 days (it is slow-growing).

Figure: Legionella pneumophila colonies in BCYE agar (Image source: Thermofischer)

Colonies are round with entire edge, glistening, convex, green, or pink iridescent, and have granular or speckled opalescence resembling ground glass.

Biochemical test characteristics

1. Motile
2. Catalase positive
3. Oxidase negative
4. Hippurate hydrolysis positive

L. pneumophila has many serogroups, and serogroup 1 accounts for the large majority (roughly 80 to 90 percent) of human infections worldwide. This fact matters for diagnosis, because the widely used urine antigen test mainly detects serogroup 1.

3. Urine Antigen Test

The urine antigen test is the most widely used rapid test for Legionnaires' disease. It detects L. pneumophila serogroup 1 antigen in urine by ELISA or immunochromatography. Its advantages explain why it is so useful: it is fast, it is highly specific (over 99 percent), its performance is not affected by prior antibiotics (unlike culture), and antigen appears within a few days of symptom onset and can persist for weeks.

Its main limitation is just as important to know: it mainly detects serogroup 1, so it can miss disease caused by other serogroups or other Legionella species. For this reason a negative urine antigen test does not fully rule out Legionnaires' disease, and culture on BCYE remains valuable for detecting non-serogroup-1 infection and for outbreak investigation.

4. Serological Test

Diagnosis can be made serologically by detecting a rise in antibody titer in the patient’s serum. Paired serum samples can be tested for a four-fold increase in antibody levels during acute and convalescent-phase specimens to confirm the diagnosis.

Treatment of Legionnaires' disease

The choice of antibiotic follows directly from the pathogenesis. Because Legionella lives inside cells, the drug has to get inside cells to reach it. The effective drugs are those that penetrate well into cells: macrolides (such as azithromycin) and respiratory fluoroquinolones (such as levofloxacin). These are the mainstays of treatment.

This also explains a key clinical point from the hook. Beta-lactam antibiotics (penicillins and cephalosporins) are ineffective against Legionnaires' disease, for two reasons. They do not penetrate into host cells to reach the intracellular organism, and Legionella also produces a beta-lactamase. So a patient with Legionnaires' disease treated with a standard beta-lactam for "ordinary" pneumonia does not improve, which is often the first clue to the diagnosis.

Pontiac fever needs no antibiotics; it resolves on its own with supportive care.

Prevention focuses on the water source, not the patient: maintaining and disinfecting cooling towers, hot-water systems, and plumbing to stop Legionella from multiplying, since the disease is acquired from water aerosols and not from other people.

Legionella and the other causes of atypical pneumonia

"Atypical pneumonia" means pneumonia that does not look like classic bacterial (typical) pneumonia: the onset is often more gradual, the cough is often dry, the chest signs can be less than the x-ray suggests, and the usual beta-lactam antibiotics often do not work because the organisms are intracellular or lack a normal cell wall. Legionella is one of several causes. The table shows how they compare.

The unifying idea: all of these are treated with macrolides, tetracyclines, or fluoroquinolones rather than beta-lactams, because none of them is a typical cell-walled extracellular bacterium sitting where a beta-lactam can act.

For the full accounts of the individual organisms, see the articles on Mycoplasma pneumoniae and Coxiella burnetii.

How to Remember

Key exam facts in one table

Where Students Get Confused

References

1. Tille, P. M. (2022). Bailey & Scott's Diagnostic Microbiology (15th ed.). Elsevier.
2. Procop, G. W., & Koneman, E. W. (2017). Koneman's Color Atlas and Textbook of Diagnostic Microbiology (7th ed.). Wolters Kluwer.
3. Carroll, K. C., Pfaller, M. A., et al. (2020). Murray's Medical Microbiology (9th ed.). Elsevier.
4. Swanson, M. S., & Hammer, B. K. (2000). Legionella pneumophila pathogenesis: a fateful journey from amoebae to macrophages. Annual Review of Microbiology, 54, 567–613.
5. Centers for Disease Control and Prevention. Legionella (Legionnaires' disease and Pontiac fever): clinical and laboratory guidance. CDC (current version).